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Abstract 
BACKGROUND: Despite the high prevalence of rheumatic mitral stenosis (MS) in Indonesia, the impact of aging 
on the anatomical and hemodynamic component of rheumatic MS is not well studied. 
AIM: To analyze the association of age with various echocardiographic parameters in patients with isolated 
severe rheumatic MS in Indonesia. 
METHODS: A cross-sectional study was conducted enrolling 263 subjects with isolated severe rheumatic MS who 
underwent transthoracic echocardiography (TTE) during January 2015 until December 2017 at National 
Cardiovascular Center of Harapan Kita, Jakarta, Indonesia. Demographic data were collected, and 
echocardiographic variables were measured based on standard TTE examination using GE Vivid 7 and S6 
Doppler Echocardiography System (GE Medical System, Norway). 
RESULTS: Of 263 subjects, there are 84 men and 179 women aged 18-80 (mean age 42.9) years old. Most 
patients had atrial fibrillation (80%), with a higher prevalence of AF in the older group. Age was positively 
correlated with LA diameter and Wilkin’s score (r = 0.186, P = 0.002; r = 0.142, P = 0.022; respectively); while 
mean MVG (r = -0.304, P < 0.001), TR Vmax (r = -0.126, P = 0.04), TR maxPG (r = -0.127, P = 0.039) and 
TAPSE (r = -0.125, P = 0.044) were correlated negatively with age. Mean MVG has the strongest correlation with 
age in our subjects.  
CONCLUSION: This is the first study in Indonesia that analyze the association of age and different 
echocardiographic parameters in isolated severe rheumatic severe MS patients. Age has a significant correlation 
with mean MVG, LA diameter, Wilkin’s score, TR Vmax, TR maxPG, and TAPSE. We assume that the 
association of age and these parameters were influenced by the normal aging process and progression of chronic 
MS. 
 
 
 
 
 
Introduction 
 
Mitral stenosis (MS) is characterized by a 
decrease in mitral valve (MV) orifice area, causing 
blood flow obstruction from left atrium to left ventricle. 
The consequence is stagnation of blood proximal to 
the MV that results in the elevated pressure of left 
atrium, pulmonary venous, pulmonary artery, and right 
heart [1], [2]. Mitral stenosis is most commonly caused 
by rheumatic heart disease (RHD) with typical 
rheumatic features such as commissural fusion, leaflet 
thickening and calcification that primarily affects the 
leaflet tips, and chordal fusion and shortening [3]. 
Mitral stenosis is highly prevalent in developing 
countries because of its association with the 
prevalence of rheumatic fever, although degenerative 
MS is now more prevalent in the developed countries 
[4], [5]. The incidence and prevalence of RHD vary 
greatly among different age groups and regions of the 
world. The global prevalence of RHD is around 1 per 
1,000 in children aged 5-14 years. There is no current 
data on the prevalence of rheumatic MS in Indonesia, 
but based on the study by Carapetis et al., Indonesia 
was included in the Asia region (East and Southeast 
Asia, excluding China and Japan) which had a 
prevalence of 0.8 per 1,000 [4].
 
The diagnosis of rheumatic MS is made 
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based on clinical examination and echocardiography 
findings. However, most symptoms occur at the later 
stage of the disease, which usually leads to late 
diagnosis and increased morbidity and mortality. Most 
RHD cases we face in the clinics in Indonesia are 
greater than moderate in severity due to low health 
literacy of the low-income population. 
Echocardiography has been used widely to confirm 
the diagnosis, determine the aetiology of MS and its 
severity, and evaluation of other valve lesions. It can 
also provide more detailed information which helps to 
decide for the management, whether it is 
percutaneous or surgical intervention [6].  
Rheumatic MS is more common in female 
and typically presents in the third or fourth decade of 
life while degenerative MS in the seventh and eighth 
decades [7]. Aging itself leads to significant 
cardiovascular structural changes, which may impact 
the pathologic process of rheumatic MS. Despite the 
high prevalence of rheumatic MS in Indonesia, the 
impact of age and ageing process on the anatomical 
and hemodynamic component of rheumatic MS is not 
well studied.  
Our study mainly focused on 
echocardiographic data (anatomical, hemodynamic 
and heart function) of isolated severe rheumatic MS 
cases in National Cardiovascular Center Harapan 
Kita, Jakarta, Indonesia, and the correlation of age 
with various echocardiographic parameters.  
 
 
Methods  
 
We conducted a cross-sectional study using 
data from the echocardiography registry of valvular 
heart disease at Harapan Kita National 
Cardiovascular Center, Jakarta, Indonesia. Total of 
263 patients with a confirmed diagnosis of isolated 
severe rheumatic MS that underwent transthoracic 
echocardiography examination from January 2015 to 
December 2017 was included in the present study. 
Diagnosis of rheumatic MS was confirmed based on 
WHO criteria and 2014 AHA/ACC Valvular Heart 
Disease Guideline [8], [9]. Severe MS is defined by a 
mitral valve area ≤ 1.0 cm
2
 either by planimetry or 
PHT method [2]. In this study, we only included 
severe isolated rheumatic MS patients without 
significant mitral regurgitation and aortic lesions. 
Patients with more than mild mitral regurgitation (MR) 
and / or aortic valve disease and history of previous 
percutaneous commissurotomy or surgical valve 
repair or replacement were excluded from this study.  
Demographic data recorded was age, sex, 
body weight and height, body surface area (BSA) and 
blood pressure. Patients were classified as in sinus 
rhythm (SR) or atrial fibrillation (AF) based on their 
baseline electrocardiogram. For display purpose, 
several data were presented in two age categories, < 
50 and ≥ 50 years old. This categorization was to 
show the value difference between younger and older 
subjects' group, cutoff age of 50 years old was chosen 
based on previous studies on aging and 
cardiovascular structural and functional changes [10].
 
Transthoracic echocardiography (TTE) 
examination was carried out in all cases using GE 
Vivid 7 and S6 Doppler Echocardiography system (GE 
Medical System, Norway). Echocardiographic 
examination was performed by experienced 
sonographers and calculated by two cardiologists. All 
echocardiographic parameters, including mitral valve 
area (MVA) by 2D planimetry and pressure half time 
(PHT) method, mean transmitral valve gradient (mean 
MVG), left atrial (LA) diameter, LA volume index 
(LAVI), left ventricular ejection fraction (LVEF), LV 
end-diastolic diameter (LVEDD), LV end-systolic 
diameter (LVESD), tricuspid annular plane systolic 
excursion (TAPSE), tricuspid regurgitation (TR) 
severity, TR maximal velocity (TR Vmax), tricuspid 
valve maximum gradient (TR maxP), pulmonary valve 
acceleration time (PV AccT), right ventricular outflow 
tract velocity time integral (RVOT VTI), Wilkin’s score, 
presence of spontaneous echo contrast (SEC) and 
thrombus at LA were assessed based on 
recommendations from the latest American Society of 
Echocardiography guidelines [11], [12], [13].
 
Baseline data, including echocardiographic 
values, were expressed descriptively, and the 
correlations between age and all echocardiographic 
parameters were analysed by Pearson’s correlation 
test. In all statistical analyses, P < 0.05 indicated a 
significant correlation between means.  
 
 
Results 
 
This study enrolled 263 patients, 84 men and 
179 women, with an age range of 18-80 (mean age 
42.9) years old. Seventy-five percent of the subjects 
aged under 50 years old. Most patients had atrial 
fibrillation (80%), but less than half of them (43%) had 
SEC at LA, and even only 42 patients (16%) appeared 
to have thrombus at LA when examined with TTE. 
Compared to the younger patients, older patients (> 
50 years old) had a higher percentage of AF (96.9% 
vs 75.1%). The severity of TR varies with mild TR is 
the most common (43.3%) followed by moderate and 
severe TR (29.3% and 20.9%, respectively). All 
patients had severe MS based on both MVA 
planimetry and PHT values that ranged between 0.3-
1.0 cm
2
, with mean MVG as low as 1.7 mmHg and 
highest of 25 mmHg (mean 12.18 mmHg). 
Interestingly, 71 patients (27%) had mean MVG lower 
than 10 mmHg, with a bigger percentage at subjects 
aged ≥ 50 years old compared to < 50 years old 
(43.9% vs 21.3%). Baseline characteristics and 
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echocardiographic values are shown in Table 1. 
Table 1: Baseline characteristics and echocardiographic 
values 
Baseline characteristics (Total N = 263) N (%) or Mean±SD 
Age (years), mean ± SD 42.94 ± 10.05 
Age (years) 
< 50 
≥ 50 
 
197 (75%) 
66 (25%) 
Gender 
Female 
Male 
 
179 (68%) 
84 (32%) 
Body height (cm) 157.6 ± 7.95 
Body weight (kg) 53.2 ± 12.09 
Atrial fibrillation 208 (80%) 
LASEC 116 (44.1%) 
LA Thrombus 42 (16.1%) 
TR severity 
Trace 
Mild 
Moderate 
Severe 
 
17 (6.5%) 
114 (43.3%) 
77 (29.3%) 
55 (20.9%) 
Echocardiographic parameters 
Mean MVG (mmHg) 
MVA PHT (cm
2
) 
MVA Planimetry (cm
2
) 
Wilkin’s score 
LAVI (ml/m
2
) 
LA diameter (cm) 
LV EF (%) 
LV EDD (cm) 
LV ESD (cm) 
TAPSE (cm) 
TR Vmax (m/s) 
TR maxPG (mmHg) 
PV AccT (ms) 
RVOT VTI (cm) 
 
12.18 ± 4.08 
0.69 ± 0.18 
0.74 ± 0.24 
7.90 ± 1.47 
126.26 ± 85.28 
5.34 ± 0.89 
60.02 ± 10.03 
4.28 ± 0.68 
2.93 ± 0.59 
1.7 ± 0.48 
3.63 ± 0.77 
55.28 ± 22.69 
88.07 ± 22.15 
11.19 ± 3.81 
 
Abbreviations: LASEC, left atrial spontaneous echo contrast; LA, left atrium; TR, tricuspid 
regurgitation; MVG, transmitral valve gradient; MVA, mitral valve area; PHT, pressure half 
time; LAVI, left atrial volume index; LV, left ventricular; EF, ejection fraction; TAPSE, 
tricuspid annular plane systolic excursion; Vmax, maximal velocity; maxPG, maximum 
pressure gradient; PV AccT, pulmonic valve acceleration time; RVOT VTI, right ventricular 
outflow tract velocity time integral; EDD, end-diastolic diameter; ESD, end-systolic 
diameter. 
 
The correlation test showed that age was 
positively correlated with LA diameter and Wilkin’s 
score (r = 0.186, P = 0.002; r = 0.142, P = 0.022; 
respectively), while negatively correlated with mean 
MVG (r = -0.304, P < 0.001), TR Vmax (r = -0.126, P 
= 0.04), TR maxPG (r = -0.127, P = 0.039) and 
TAPSE (r = -0.125, P = 0.044) (Table 2).  
Figure 1: Frequency of subjects with means MVG < 10 mmHg and 
≥ 10 mmHg in younger (< 50 years old) and older age (≥ 50 years 
old) groups 
 
 Among these parameters, mean MVG has the 
strongest correlation with age in our subjects. Majority 
of the younger subjects (< 50 years old) had higher 
mean MVG, 155 (78.7%) subjects with mean MVG ≥ 
10 mmHg compared to 42 (21.3%) subjects with 
mean MVG < 10 mmHg. Meanwhile, this proportion 
shifted among older subjects (≥ 50 years old). The 
percentage of older patients with lower MVG was 
higher than the younger subjects, where 29 (43.9%) 
subjects with mean MVG < 10 mmHg and 37 (56.1%) 
subjects with mean MVG ≥ 10 mmHg (Figure 1). 
Table 2: Correlation of age and various echocardiographic 
parameters 
Parameters Age (years) 
r P 
Mean MVG (mmHg) 
MVA PHT (cm
2
) 
MVA Planimetry (cm
2
) 
Wilkin’s score 
LAVI (ml/m
2
) 
LA diameter (cm) 
LV EF (%) 
LV EDD (cm) 
LV ESD (cm) 
TAPSE (cm) 
TR Vmax (m/s) 
TR maxPG (mmHg) 
PV AccT (ms) 
RVOT VTI (cm) 
-0.314 
0.093 
0.012 
0.142 
0.098 
0.186 
-0.017 
-0.030 
-0.008 
-0.125 
-0.126 
-0.127 
-0.046 
0.061 
<0.001* 
0.131 
0.853 
0.022* 
0.113 
0.002* 
0.779 
0.623 
0.900 
0.044* 
0.041* 
0.039* 
0.462 
0.333 
*Statistically significant. 
 
 
 
Discussion  
 
In our study, there were more patients under 
the age of fifty years, with a percentage of 75% of the 
total sample. This is in accordance with the results of 
other studies which showed the highest prevalence of 
rheumatic MS is in adults aged 20–50 years [4], [14]. 
Both rheumatic MS and mitral annular calcification 
have been described in previous studies to be more 
common in women, two to four times more prevalent 
in women than men, whereas mitral regurgitation has 
similar prevalence between men and women [14], 
[15], [16]. Our study showed a marked female 
predominance in isolated rheumatic MS with a two-
fold higher incidence in women than men. The 
scientific reasons for this female predominance had 
not been well explained, but some studies had 
proposed that it might be associated with social 
factors such as childbearing, which might increase 
exposure to group A streptococcus, access to health 
care, and genetic factors that predispose women to 
autoimmune diseases [14]. 
Mitral stenosis is associated with increased 
LA stiffness, LA remodelling, and abnormal 
contractility. In the setting of MS, LA enlargement due 
to pressure overload is usually secondary to 
increased LA afterload. This causes LA compliance 
reduction, increased LA and pulmonary pressures and 
right heart failure [17]. The impact of ageing on LA 
size had been established at the study by Nikitin et al., 
LA diameter was increased with age with significantly 
higher LA diameter in the oldest subjects [18]. This 
supports our study finding that LA diameter had a 
significant positive correlation with age in our study, 
which means that the older the patient, the bigger or 
more dilated the LA. 
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Epidemiological studies had shown that 
generally, the prevalence and incidence of AF 
increased steeply after 65 years of age [19].
 
Atrial 
fibrillation and LA thrombus frequently complicate 
rheumatic mitral valve disease with 30-40% of 
patients had AF in long-term follow-up. The 
occurrence of AF correlates well with LA size; the 
incidence of AF increases from 3% when LA diameter 
is < 40mm to 54% if LA diameter is > 40 mm [20]. A 
study by Kim et al., showed that the annual AF 
development rate was 3.5% in rheumatic MS patients 
with sinus rhythm that increased with LA size and MS 
severity. Meanwhile, MS patients with enlarged LA 
had an average AF development rate of 6.0% per 
year [21]. In rheumatic MS, enlarged LA combined 
with older age leads to very high AF prevalence as 
shown by our subjects. Eighty-percent of our subjects 
had AF, which is an even bigger percentage 
compared to previous studies. Almost all of older 
patients in our study had AF (96.9%). González-
Torrecilla et al. found that the prevalence of SEC and 
thrombus at LA observed by TTE and 
transesophageal echocardiography (TEE) in MS 
patients with chronic AF is 52% and 29.5% [22].
 
In this 
study, the prevalence of SEC and thrombus is 43% 
and 16%. This lower prevalence in our study might be 
due to our method that only included results from TTE 
since thrombus at LA and LA appendage is easier to 
observe during TEE study.  
Currently, there are no studies on the impact 
of age on the size of MVA by any measurement 
methods. MVA is one criterion to determine the 
anatomical severity of rheumatic MS, and in our study, 
we only included severe rheumatic MS patients (MVA 
≤ 1.0 cm
2
). Our study showed no correlation between 
age and both MVA planimetry and MVA PHT. We 
assumed that the degree of the valve stenosis is 
rather fixed throughout life and not being progressive 
over the years. Interestingly, Wilkin’s score, that 
defines mitral valve score by calculating the individual 
subcomponent scores, including leaflet thickening and 
mobility, valve calcification, and subvalvular disease, 
is significantly correlated with age in our study. 
Ramakrishna and Kanattu had shown that despite the 
similarity in MVA between younger and older subjects, 
total mitral valve score < 8 was more common in the 
younger group with score > 11 was statistically more 
common in the older group. Older patients had higher 
leaflet calcification and subvalvular thickening score (> 
2) compared to younger patients [23]. Older patients 
tend to have higher degenerative changes, although 
these changes might not have an impact on the 
degree of the mitral stenosis severity. Thus, older 
patients might not be suitable for percutaneous 
commissurotomy due to higher Wilkin’s score. For 
cardiologists, this data will help decide the 
management of older rheumatic MS patients. 
Mean MVG or the transmitral pressure 
gradient represents hemodynamic severity rather than 
anatomic severity and more closely associated with 
the patient’s hemodynamic status. Mean MVG had the 
strongest significant correlation with age in our study 
(r = -0.314, P < 0.001). It is inversely correlated with 
age. Thus older patients had lower mean MVG. A 
recent study that supports our finding is by El 
Sabbagh et al., which showed patients with low 
gradient severe MS (mean MVG < 10 mmHg) were 
older when compared to high gradient MS (mean age 
65 ± 10 vs 56 ± 13 years old, P < 0.001) [24]. 
Although it had not been studied before, lower mean 
MVG in older patients might be due to several 
cardiovascular changes that happen with the normal 
aging process, including increased LV end-diastolic 
pressure, decreased LA compliance, higher heart rate 
and lower cardiac output [10].
 
Mitral stenosis itself 
increases LA pressure that leads to a reduction of LA 
compliance [17]. As chronic rheumatic MS patients 
get older, these factors will gradually lead to 
hemodynamic changes that cause lower mean MVG. 
Other factors that influence mean MVG are MVA, 
heart rate, cardiac output, LV and LA compliance, and 
other associated valve lesions. We excluded other 
significant mitral and aortic valve diseases, and our 
patients had similar MVA regardless of the age 
difference. Therefore, the mean MVG was not 
influenced by these factors in our study. 
In patients with severe MS, persistently raised 
LA pressure results in pulmonary venous 
hypertension, reflex pulmonary arteriolar constriction, 
obliterative changes in the pulmonary vascular bed, 
pulmonary artery hypertension (PAH), RV hypertrophy 
and dilatation and tricuspid valve dysfunction [25].
 
Peak TR velocity (TR Vmax) is used to measure the 
pressure difference between the right atrium (RA) and 
RV using simplified Bernoulli equation (P = 4 
[TRmax]
2
) [26]. This method correlates well with 
PASP on right heart catheterisation [27]. Elevated TR 
Vmax (≥ 2.8 m/s) is highly accurate in correctly 
identifying pulmonary hypertension [28].
 
Our findings 
showed high TR Vmax and TR maxPG with low PV 
AccT and RVOT VTI, which all support the signs of 
pulmonary hypertension in rheumatic severe MS 
patients. Both TR Vmax and TR maxPG had a 
significant negative correlation with age (r = -0.126, P 
= 0.04; r = -0.127, P = 0.039; respectively). Several 
studies showed that pulmonary hypertension is 
greater in younger patients. Sinha et al. found that 
mean pulmonary arterial pressure and pulmonary 
vascular resistance are greater in juvenile MS patients 
compared to adults [29]. Studies by Tandon et al. and 
Ramakrishna and Kanattu showed that more severe 
pulmonary vascular changes and significant 
pulmonary hypertension were more common in 
younger patients [23], [30].
 
Lower TR Vmax and TR 
maxPG in elderly might also caused by greater RA 
and RV dilation which creates equalisation of RA and 
RV pressures, leading to underestimation of PA 
pressure by echocardiography.  
Age is also correlated negatively with TAPSE 
in our study. TAPSE, which represents RV systolic 
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function, decreases with age [31].
 
RV hypertrophy and 
dilation due to chronic MS also leads to reduced RV 
function [25]. This pathophysiological changes in older 
rheumatic MS patients explain the mechanism of 
reduced TAPSE in this study. 
 
In conclusion, this study is the first one that 
analyzes the correlation of age and different 
echocardiographic parameters in isolated severe 
rheumatic MS patients. Mean MVG had the strongest 
significant correlation with age in our study. Age had a 
significant positive correlation with LA diameter and 
Wilkin’s score, while mean MVG, TR Vmax, TR 
maxPG, and TAPSE were found to be negatively 
correlated with age. The impact of the aging process 
on cardiovascular changes combined with a 
progression of chronic MS as the patient gets older 
leads to the association of those echocardiographic 
parameters with age. Our study results will help 
cardiologists, especially in a developing country who 
deal with more rheumatic MS patients, to understand 
more on the impact of ageing on the progression of 
rheumatic MS. 
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